MapLight Therapeutics, Inc.MapLight Therapeutics, Inc.MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc.

No trades
No trades

Fundamentals and stats

Operating, investing, and financing activities

Free cash flow for Q2 26 is ‪−44.89 M‬ USD. For 2025, it was ‪−138.61 M‬ USD and operating cash flow was ‪−138.14 M‬ USD.

2022
2023
2024
2025
Cash flow from operating activities
Cash flow from investing activities
Cash flow from financing activities
MetricsCurrency: USD
2022
2023
2024
2025
TTM